Monday, October 4, 2010
Latest News - Prolia
We are now offering Prolia injections at our Tulsa office in continuing our tradition of bringing the latest, FDA approved treatment options to our patients with osteoporosis.
Prolia (denosumab) is the first drug approved by the FDA in an entirely new class of osteoporosis-fighting medications known as RANKL, or RANK ligand inhibitors. These medications work decrease bone loss in a way that is different from other osteoporosis medications (such as Fosamax, Boniva, etc.)
Our patients who have chosen Prolia so far have done so mostly because it is better tolerated than some oral medications such as Fosamax. In addition, convenience can play a role as Prolia is typically given every 6 months, rather than every day.
Compared to other injectable therapies done by intravenous (IV) infusion, Prolia can be injected in office under the skin, much like a flu shot. This typically takes about 15 minutes, including observation afterwards.
If you are interested in Prolia, or for more information, call our office at (918) 260-9322.
The newly approved drug, denosumab (Prolia), is an injectable medication derived from a synthetic antibody. It is approved by the FDA for treating postmenopausal women with osteoporosis and other patients who have failed or couldn't tolerate other medications.